News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Dana-Farber’s Breast Oncology Center is leading a phase 2 study called TRUDI
dana-farber.org
Nov 26, 2024, 17:58

Dana-Farber’s Breast Oncology Center is leading a phase 2 study called TRUDI

Dana-Farber’s Breast Oncology Center shared a post on X:

“We are leading a phase 2 study, called TRUDI, to test the safety and effectiveness of an investigational drug combination (trastuzumab deruxtecan and durvalumab) to learn if the intervention works in stage III, HER2-expressing Inflammatory Breast Cancer.”

Dana-Farber’s Breast Oncology Center is leading a phase 2 study called TRUDI

Read further.

More featuring Dana-Farber’s Breast Oncology Center.

cancer Dana-Farber’s Breast Oncology Center Durvalumab inflammatory breast cancer OncoDaily Oncology Trastuzumab deruxtecan TRUDI
Special Coverage
Blog
Nov 26, 2024, 17:58
Dana-Farber’s Breast Oncology Center is leading a phase 2 study called TRUDI
Blog
Nov 26, 2024, 17:51
Vincent Rajkumar: All you need to know about myeloma in a podcast format
Blog
Nov 26, 2024, 17:51
RNA-Targeting CRISPR Uncovers Hundreds of Essential Noncoding RNAs in Human Development and Cancer
Blog
Nov 26, 2024, 17:44
Fight Colorectal Cancer representatives at the White House and ACS CAN Policy Meetings
Blog
Nov 26, 2024, 17:35
Enrique Grande: Couldn’t find a better host like Carolina Ibanez and a better partner in crime than Shilpa Gupta
Blog
Nov 26, 2024, 17:23
Misty Dawn Shields: Vibrant case discussion of alterations in PD-L1 negative LUAD with Eric Singh
Blog
Nov 26, 2024, 17:15
Ibrahim Halil Sahin: The Pittsburgh Second Annual GI Cancer Summit
Blog
Nov 26, 2024, 17:05
Tracey O'Brien: 2024 NSW Premier’s Awards for Outstanding Cancer Research
Blog
Nov 26, 2024, 16:59
Centering the Unique Needs and Experiences of Cancer Patients No Matter the Political Environment - BrightEdge - ACS
Blog
Nov 26, 2024, 16:48
Amr M.Elhadidy: Successfully passed the ESMO examination 2024
Blog
Nov 26, 2024, 16:42
Tian Zhang: STAREV is open and enrolling UTSW Simmons Cancer Center
Blog
Nov 26, 2024, 16:37
Exciting Opportunity for Liquid Biopsy Research by the Brain Tumor Funders Collaborative - International Society of Liquid Biopsy